Pulike Biological Engineering, Inc.(603566.SH): "Prilamin oral solution" has obtained a new animal drug registration certificate.

Pulike Biological Engineering, Inc. (603566.SH) announced that, in accordance with the "Regulations on Veterinary Drugs Management" and the "Measures for the Registration of Veterinary Drugs," the company and its wholly-owned subsidiary, Luoyang Huizhong Veterinary Drugs Co., Ltd. (referred to as "Huizhong Veterinary Drugs" hereafter), jointly applied for the registration of "Prilabalin oral solution" as a new veterinary drug, which has been approved by the Ministry of Agriculture and Rural Affairs after review. The acquisition of the certificate for this new veterinary drug is a result of the company's continued emphasis on technological innovation and increased investment in research and development. It enriches the company's product range in the pet medication sector, enhances the market competitiveness of the company's pet products, and brings new growth opportunities for the company's pet segment.